Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients
L Pagano, C G Valentini, V De Stefano, et al.
Leukemia Research
|
January 21, 2015
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction
F Ramos, S Thépot, L Pleyer, et al.
Oncogene
|
October 4, 2011
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets
S Berardi, A Caivano, R Ria, et al.
Leukemia
|
December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma
S Bringhen, M D'Agostino, L De Paoli, et al.
Scientific Reports
|
February 8, 2020
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling
A Romano, N L Parrinello, V Simeon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2013
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
S Luminari, I Biasoli, L Arcaini, et al.
Leukemia Research
|
February 21, 2023
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
L Maurillo, A Spagnoli, A Candoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2014
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
S Luminari, I Biasoli, A Versari, et al.
Leukemia
|
September 22, 2012
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients
P Falco, F Cavallo, A Larocca, et al.
Leukemia
|
June 4, 2011
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
F Cavallo, S Bringhen, G Milone, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients
L Pagano, C G Valentini, V De Stefano, et al.
Leukemia Research
|
January 21, 2015
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction
F Ramos, S Thépot, L Pleyer, et al.
Oncogene
|
October 4, 2011
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets
S Berardi, A Caivano, R Ria, et al.
Leukemia
|
December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma
S Bringhen, M D'Agostino, L De Paoli, et al.
Scientific Reports
|
February 8, 2020
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling
A Romano, N L Parrinello, V Simeon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2013
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
S Luminari, I Biasoli, L Arcaini, et al.
Leukemia Research
|
February 21, 2023
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
L Maurillo, A Spagnoli, A Candoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2014
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
S Luminari, I Biasoli, A Versari, et al.
Leukemia
|
September 22, 2012
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients
P Falco, F Cavallo, A Larocca, et al.
Leukemia
|
June 4, 2011
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
F Cavallo, S Bringhen, G Milone, et al.
Page
of 12